Methylnaltrexone Use for Opioid-induced Postoperative Constipation
Completed · Phase 4
Conditions studied: Constipation
In brief
The purpose of this study is to determine whether the routine use of methylnaltrexone in the post-operative pediatric spinal fusion patient will decrease the incidence of constipation.
Key facts
- Study ID
- NCT01773096
- Run by
- Shriners Hospitals for Children
- People needed
- 60
- Starts
- 2013-05-01
- Expected to finish
- 2015-05-01
- Last updated by the study team
- 2015-05-19
Who can join
Age: 12 and older, up to 21. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- spinal fusion surgery
- current opioid use
- 12 years of age and older
- no or inadequate bowel movement by post-operative day 3
You may not qualify if…
- known or expected mechanical bowel obstruction
- known or suspected lesions of the GI tract
- unexpected transfer to ICU
- unexpected return to the operating room
- patient or parent refusal of methylnaltrexone
- incomplete data concerning time to laxation
Where it is running
- Shriners Hospitals for Children- Spokane — Spokane, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.